248 related articles for article (PubMed ID: 34542165)
1. lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR‑424‑5p/LATS1 axis.
Han X; Jia Y; Chen X; Sun C; Sun J
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34542165
[TBL] [Abstract][Full Text] [Related]
2. TINCR suppresses proliferation and invasion through regulating miR-544a/FBXW7 axis in lung cancer.
Liu X; Ma J; Xu F; Li L
Biomed Pharmacother; 2018 Mar; 99():9-17. PubMed ID: 29324317
[TBL] [Abstract][Full Text] [Related]
3. LINC00518 affects the proliferation, invasion and migration of cutaneous malignant melanoma cells via miR-526b-3p/EIF5A2 axis.
Xu J; Zhang F; Lin M; Tong Y
Acta Biochim Pol; 2022 Feb; 69(1):101-111. PubMed ID: 35189053
[TBL] [Abstract][Full Text] [Related]
4. LncRNA TINCR/microRNA-107/CD36 regulates cell proliferation and apoptosis in colorectal cancer via PPAR signaling pathway based on bioinformatics analysis.
Zhang X; Yao J; Shi H; Gao B; Zhang L
Biol Chem; 2019 Apr; 400(5):663-675. PubMed ID: 30521471
[TBL] [Abstract][Full Text] [Related]
5. miR‑589‑3p sponged by the lncRNA TINCR inhibits the proliferation, migration and invasion and promotes the apoptosis of breast cancer cells by suppressing the Akt pathway via IGF1R.
Guo F; Zhu X; Zhao Q; Huang Q
Int J Mol Med; 2020 Sep; 46(3):989-1002. PubMed ID: 32705168
[TBL] [Abstract][Full Text] [Related]
6. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
Chen X; Gao J; Yu Y; Zhao Z; Pan Y
Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA terminal differentiation-induced non-coding RNA regulates cisplatin resistance of choroidal melanoma by positively modulating extracellular signal-regulated kinase 2 via sponging microRNA-19b-3p.
Li W; Nie A; Jin L; Cui Y; Xie N; Liang G
Bioengineered; 2022 Feb; 13(2):3422-3433. PubMed ID: 35067169
[TBL] [Abstract][Full Text] [Related]
8. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
Su BB; Zhou SW; Gan CB; Zhang XN
J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
[TBL] [Abstract][Full Text] [Related]
9. LINC01296 promotes proliferation of cutaneous malignant melanoma by regulating miR-324-3p/MAPK1 axis.
Wang K; Luo Q; Zhang Y; Xie X; Cheng W; Yao Q; Chen Y; Ren H; Li J; Pan Z
Aging (Albany NY); 2022 Dec; 15(8):2877-2890. PubMed ID: 36462499
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA LINC00518 induces radioresistance by regulating glycolysis through an miR-33a-3p/HIF-1α negative feedback loop in melanoma.
Liu Y; He D; Xiao M; Zhu Y; Zhou J; Cao K
Cell Death Dis; 2021 Mar; 12(3):245. PubMed ID: 33664256
[TBL] [Abstract][Full Text] [Related]
11. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
Pang R; Yang S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
[TBL] [Abstract][Full Text] [Related]
12. Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells.
Zhang W; Zhou K; Zhang X; Wu C; Deng D; Yao Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649811
[TBL] [Abstract][Full Text] [Related]
13. Silencing the long noncoding RNA, TINCR, a molecular sponge of miR‑335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression.
Li R; Wang Y; Xu Y; He X; Li Y
Int J Oncol; 2019 Nov; 55(5):1110-1124. PubMed ID: 31545411
[TBL] [Abstract][Full Text] [Related]
14. TINCR inhibits the proliferation and invasion of laryngeal squamous cell carcinoma by regulating miR-210/BTG2.
He G; Pang R; Han J; Jia J; Ding Z; Bi W; Yu J; Chen L; Zhang J; Sun Y
BMC Cancer; 2021 Jun; 21(1):753. PubMed ID: 34187411
[TBL] [Abstract][Full Text] [Related]
15. SP1-induced lncRNA TINCR overexpression contributes to colorectal cancer progression by sponging miR-7-5p.
Yu S; Wang D; Shao Y; Zhang T; Xie H; Jiang X; Deng Q; Jiao Y; Yang J; Cai C; Sun L
Aging (Albany NY); 2019 Mar; 11(5):1389-1403. PubMed ID: 30853664
[TBL] [Abstract][Full Text] [Related]
16. lncRNA TINCR facilities bladder cancer progression via regulating miR‑7 and mTOR.
Xu G; Yang H; Liu M; Niu J; Chen W; Tan X; Sun L
Mol Med Rep; 2020 Nov; 22(5):4243-4253. PubMed ID: 33000269
[TBL] [Abstract][Full Text] [Related]
17. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.
Dong H; Hu J; Zou K; Ye M; Chen Y; Wu C; Chen X; Han M
Mol Cancer; 2019 Jan; 18(1):3. PubMed ID: 30621694
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of lncRNA TINCR is associated with high-grade, invasive, and recurring tumors, and facilitates proliferation in vitro and in vivo of urothelial carcinoma of the bladder.
Han Y; Sun G
Urol Oncol; 2020 Sep; 38(9):738.e1-738.e8. PubMed ID: 32622721
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis.
Zhao H; Xie Z; Tang G; Wei S; Chen G
J Cell Physiol; 2020 Oct; 235(10):6990-7002. PubMed ID: 31994189
[TBL] [Abstract][Full Text] [Related]
20. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.
Gao W; Chen X; Chi W; Xue M
Int J Mol Med; 2020 Nov; 46(5):1743-1754. PubMed ID: 33000222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
